» Articles » PMID: 20231538

Homocysteine Lowering in End-stage Renal Disease: is There Any Cardiovascular Benefit?

Overview
Journal Circulation
Date 2010 Mar 17
PMID 20231538
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Plasma Homocysteine Levels and Cardiovascular Events in Patients With End-Stage Renal Disease: A Systematic Review.

ALSolami A, Almalki A, Alhedyan S, Alghamdi A, Alzahrani S, Dause W Cureus. 2023; 15(6):e40357.

PMID: 37456428 PMC: 10339662. DOI: 10.7759/cureus.40357.


Association between homocysteinemia and mortality in CKD: A propensity-score matched analysis using NHANES-National Death Index.

Song J, Huh H, Bae E, Lee J, Lee J, Lee J Medicine (Baltimore). 2022; 101(36):e30334.

PMID: 36086712 PMC: 10980502. DOI: 10.1097/MD.0000000000030334.


Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?.

Cianciolo G, De Pascalis A, Di Lullo L, Ronco C, Zannini C, La Manna G Cardiorenal Med. 2017; 7(4):255-266.

PMID: 29118764 PMC: 5662962. DOI: 10.1159/000471813.


The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: "Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer". Molecules 2017, 22, 582, pii: E582.

Cianciolo G, Cappuccilli M, La Manna G Molecules. 2017; 22(7).

PMID: 28753969 PMC: 6152384. DOI: 10.3390/molecules22071216.


Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.

Clase C, Ki V, Holden R Semin Dial. 2013; 26(5):546-67.

PMID: 23859229 PMC: 4285924. DOI: 10.1111/sdi.12099.